Illinois Oncology Research Association CCOP

伊利诺伊州肿瘤学研究协会 CCOP

• 批准号: 7117463
• 负责人: JOHN W KUGLER
• 金额: $ 95.65万
• 依托单位: ONCOLOGY-HEMATOLOGY ASSOC-CENTRAL ILL
• 依托单位国家: 美国
• 财政年份: 1983
• 资助国家: 美国
• 起止时间: 1983-09-01 至 2009-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7117463
• 关键词: allied health education; behavioral /social science research tag; cancer information system; cancer prevention; cancer registry /resource; cancer rehabilitation /care; chemoprevention; clinical research; clinical trials; colorectal neoplasms; community health services; cooperative study; early diagnosis; ethnic group; female reproductive system neoplasm; health care quality; health care referral /consultation; health care service availability; health services research tag; human subject; human therapy evaluation; male reproductive system neoplasm; medical outreach /case finding; medical rehabilitation related tag; medically underserved population; melanoma; neoplasm /cancer diagnosis; neoplasm /cancer education; neoplasm /cancer therapy; oral pharyngeal neoplasm; patient /disease registry; primary care physician; public health; rural area

The long-term objectives of the Illinois Oncology Research Association Community Clinical Oncology Program (IORA CCOP), based in Peoria, IL, remain essentially unchanged as it continues to work within a community setting toward preventing, treating, recovering from and curing cancer. Specifically, the IORA (:COP seeks to expand cancer clinical research in the communities of central and western Illinois; stimulate quality care throughout the community through participation in clinical research trials; promote the continued growth of a scientifically viable community cancer network to work with NCI-sponsored cooperative group trials; promote cancer prevention, control, and treatment by educating health care professionals and the public on the importance of cancer prevention, early detection, proper treatment and continuing careand by involving primary care physicians and other specialists in cancer prevention trials; add to the knowledge base of known and new cancer treatments; and encourage the involvement of racial minorities, women and rural patients (i.e. underserved populations) in clinical trials. The IORA CCOP and its affiliates offer access to cancer clinical trials in an 18-county catchment area. This area spans nearly 12,000 square miles of mostly rural country, yet most patients are easily within a one hour drive of one of IORA CCOP's 26 affiliates in 16 communities. Although 5 of the affiliates are in Peoria itself, the IORA CCOP medical oncologists travel to 16 communities outside Peoria weekly' and all communities are supported by the affiliated radiation facilities in the region. The IORA CCOP uses state-of-the-art research protocols from the North Central Cancer Treatment Group (NCCTG), Eastern Cooperative Oncology Group (ECOG), Cancer and Leukemia Group B (CALGB), National Surgical Adjuvant Breast and Bowel Project (NSABP), and MD Anderson CancerCenter (MDACC). The IOEA CCOP enjoys excellent working relationships with these groups. Its centralized record keeping and quality control systems, its years of clinical trials experience, the expertise of its staff and the commitment of the CCOP oncology team all lend themselves to continued quality research conducted in a community setting and resulting in patient benefit and documented results.

伊利诺伊州肿瘤学研究协会社区临床肿瘤学计划（IORA CCOP）的长期目标基本保持不变，因为它继续在社区环境中工作，以预防，治疗，康复和治愈癌症。具体而言，IORA（：COP旨在扩大伊利诺伊州中部和西部社区的癌症临床研究;通过参与临床研究试验，促进整个社区的优质护理;促进科学上可行的社区癌症网络的持续发展，与NCI赞助的合作组试验合作;透过教育医护专业人员及公众认识预防癌症、及早发现癌症，适当的治疗和持续的护理，并让初级保健医生和其他专家参与癌症预防试验; 增加已知和新的癌症治疗知识库;鼓励少数民族、妇女和农村病人（即得不到充分服务的人口）参与临床试验。 IORA CCOP及其附属机构在18个县的集水区提供癌症临床试验。该地区跨越近12,000平方英里的农村地区，但大多数患者都很容易在一个小时的车程之一IORA CCOP的26个分支机构在16个社区。虽然有5个附属机构在皮奥里亚，但IORA CCOP的医学肿瘤学家每周前往皮奥里亚以外的16个社区，所有社区都得到该地区附属辐射设施的支持。 IORA CCOP使用来自中北部癌症治疗组（NCCTG）、东部肿瘤协作组（ECOG）、癌症和白血病组B（CALGB）、国家外科辅助乳腺和肠道项目（NSABP）和MD安德森癌症中心（MDACC）的最新研究方案。IOEA CCOP与这些团体保持着良好的工作关系。其集中的记录保存和质量控制系统，多年的临床试验经验，其工作人员的专业知识和CCOP肿瘤学团队的承诺都有助于在社区环境中进行持续的高质量研究，并为患者带来益处和记录结果。